simvastatin has been researched along with Cardiomyopathies in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Duvall, WL; Thompson, PD | 1 |
| Wang, Y; Yang, W; Zhang, L; Zhang, R; Zhao, X | 1 |
| Amidžić, L; Gajanin, R; Jaćević, V; Kuča, K; Nežić, L; Škrbić, R | 1 |
| Adams, ME; Bible, KL; Froehner, SC; Kim, MJ; Regnier, M; Whitehead, NP | 1 |
| Buerke, M; Buerke, U; Carter, JM; Grandel, U; Grimminger, F; Mueller-Werdan, U; Russ, M; Schlitt, A; Schmidt, H; Seeger, W; Sibelius, U; Werdan, K | 1 |
| Leung, AA; van Walraven, C | 1 |
| Chia, PL; Lee, E | 1 |
| Abraham, SS; Homma, S; Liao, JK; Mital, S; Osorio, JC; Thaker, HM; Wang, J | 1 |
| Becker, KA; Farmer, JA; Koerner, MM; Küçüker, SA; McRee, SC; Noon, GP; Stetson, SJ; Torre-Amione, G; Wallace, CK | 1 |
| Ichihara, K | 1 |
2 review(s) available for simvastatin and Cardiomyopathies
| Article | Year |
|---|---|
Reviewing the medical literature: five notable articles in general internal medicine from 2010 and 2011.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Azetidines; Cardiomyopathies; Ezetimibe; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk; Seizures; Simvastatin; Ultrasonography; Warfarin | 2012 |
[Myocardial dysfunction].
Topics: Animals; Cardiomyopathies; Clinical Trials as Topic; Coenzymes; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Stunning; Myocardium; Oils; Pravastatin; Simvastatin; Solubility; Ubiquinone; Water | 2006 |
1 trial(s) available for simvastatin and Cardiomyopathies
| Article | Year |
|---|---|
Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients.
Topics: Aged; Biomarkers; Cardiomyopathies; Combined Modality Therapy; Female; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Simvastatin; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
7 other study(ies) available for simvastatin and Cardiomyopathies
| Article | Year |
|---|---|
Tendonopathy Due to Simvastatin and Ezetimibe, Amyloidosis or Both?
Topics: Amyloidosis; Cardiomyopathies; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Simvastatin; Tendinopathy | 2020 |
An experimental study of the protective effect of simvastatin on sepsis-induced myocardial depression in rats.
Topics: Animals; Cardiomyopathies; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardium; Myocytes, Cardiac; NF-kappa B; Rats; Rats, Wistar; Sepsis; Signal Transduction; Simvastatin; Toll-Like Receptor 4; Transcription Factor RelA | 2017 |
Simvastatin Protects Cardiomyocytes Against Endotoxin-induced Apoptosis and Up-regulates Survivin/NF-κB/p65 Expression.
Topics: Administration, Oral; Animals; Apoptosis; Cardiomyopathies; Caspase 3; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipopolysaccharides; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Sepsis; Signal Transduction; Simvastatin; Survivin; Transcription Factor RelA; Up-Regulation | 2018 |
Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
Topics: Animals; Autonomic Nervous System; Calcium-Binding Proteins; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart; Heart Rate; Male; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocytes, Cardiac; Phosphorylation; Recovery of Function; Simvastatin; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy.
Topics: Animals; Apoptosis; Cardiomyopathies; Exotoxins; Heart; Hemodynamics; In Situ Nick-End Labeling; In Vitro Techniques; Myocardium; Necrosis; Rats; Sepsis; Simvastatin; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2008 |
Reverse Takotsubo pattern stress cardiomyopathy in a male patient induced during dobutamine stress echocardiography.
Topics: Aspirin; Bisoprolol; Cardiomyopathies; Cardiotonic Agents; Chest Pain; Dobutamine; Echocardiography, Stress; Enalapril; Humans; Male; Middle Aged; Simvastatin | 2012 |
Simvastatin preserves cardiac function in genetically determined cardiomyopathy.
Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Cardiomyopathies; Caspase 3; Caspases; Cricetinae; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Male; Nitric Oxide; Simvastatin; Ventricular Function, Left | 2004 |